Comorbidities and mortality associated with hospitalized heart failure in Canada

Sulan Dai1, Peter Walsh, Andy Wielgosz

  • 1Public Health Agency of Canada, Ottawa, Ontario, Canada. Sulan.Dai@phac-aspc.gc.ca

Insights

Heart failure (HF) significantly increases hospital mortality and length of stay, especially in seniors. This condition is linked to numerous comorbidities, burdening the Canadian healthcare system.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Heart failure (HF) is a primary cause of hospitalization and mortality.
  • HF frequently co-occurs with other medical conditions, escalating healthcare costs.
  • Understanding HF's impact on hospital outcomes and associated comorbidities is crucial.

Purpose of the Study:

  • To describe in-hospital mortality rates for heart failure (HF).
  • To identify comorbid conditions frequently associated with HF hospitalizations.
  • To assess the impact of HF on hospital stay duration and healthcare burden in Canada.

Main Methods:

  • Analysis of acute care hospital separations data from 2005-2006 across Canadian provinces (excluding Québec).
  • Identification of hospitalizations with a primary diagnosis of heart failure (ICD-10-CA codes I50, I500, I501, I509).
  • Examination of comorbid diagnoses, mortality rates, and hospital stay lengths for HF patients compared to the general hospitalized population.

Main Results:

  • Heart failure (HF) was the primary diagnosis in 1.9% of hospitalizations (42,399 separations) and a comorbid diagnosis in 4.9% of all hospitalizations.
  • Individuals hospitalized with HF experienced a nearly 3-fold higher 30-day in-hospital mortality rate and a doubled mean hospital stay.
  • HF patients averaged 3.9 comorbidities, with chronic ischemic heart disease, atrial fibrillation, and diabetes being most common; this is 1.7 times higher than for all causes.

Conclusions:

  • Heart failure (HF) is associated with substantial in-hospital mortality, particularly in the elderly population.
  • The high prevalence of comorbidities in HF patients contributes to prolonged hospital stays and increased healthcare system burden.
  • Effective management of HF and its associated conditions is essential to mitigate its impact on Canadian healthcare resources.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...